| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10007956 | HBV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS10007957 | HBV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS10003449 | HBV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS10021757 | HBV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS10030462 | HBV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS10048853 | HBV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS20002820 | HPV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS20040814 | HPV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS20059132 | HPV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
| TVIS20013329 | HPV | ENSG00000145863.11 | protein_coding | GABRA6 | Yes | No | 2559 | Q16445 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GABRA6 |
|---|---|
| DrugBank ID | DB00371 |
| Drug Name | Meprobamate |
| Target ID | BE0000764 |
| UniProt ID | Q16445 |
| Regulation Type | agonist |
| PubMed IDs | 9067327; 19244096 |
| Citations | Rho JM, Donevan SD, Rogawski MA: Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther. 1997 Mar;280(3):1383-91.@@Gonzalez LA, Gatch MB, Taylor CM, Bell-Horner CL, Forster MJ, Dillon GH: Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies. J Pharmacol Exp Ther. 2009 May;329(2):827-37. doi: 10.1124/jpet.109.151142. Epub 2009 Feb 24. |
| Groups | Approved; Illicit |
| Direct Classification | Carbamate esters |
| SMILES | CCCC(C)(COC(N)=O)COC(N)=O |
| Pathways | Capecitabine Metabolism Pathway; Capecitabine Action Pathway |
| PharmGKB | PA450377 |
| ChEMBL | CHEMBL979 |
